Lion Point Capital, LP Imara Inc. Transaction History

Lion Point Capital, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$1.15 - $2.41 $959,996 - $2.01 Million	834,780 New	834,780 $1.57 Million
Q4 2021 Feb 14, 2022	SELL	$2.25 - $4.05 $1.87 Million - $3.37 Million	-833,333 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.08 - $7.83 $3.4 Million - $6.52 Million	833,333 New	833,333 $3.4 Million

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Lion Point Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Lion Point Capital, LP with notifications on news.